Aspirin as Primary Prevention of Acute Coronary Heart Disease Events

Journal Title: Journal of Advances in Medicine and Medical Research - Year 2014, Vol 4, Issue 34

Abstract

Background/Objective: Aspirin for primary prophylaxis is controversial. This study evaluated associations between prophylactic aspirin use and incident acute coronary heart disease (CHD) events. Methods and Results: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study was accessed for aspirin use examining black and white hazards for incident CHD, for men and women, each adjusting incrementally for sampling, socio-demographics, and CHD risk factors. Stratified models examined risks across strata of the Framingham risk score, and all-cause mortality. 23,949 participants (mean 64 yo), had 503 incident events over a 3.5 year follow-up. Prophylactic aspirin use was not associated with incident acute CHD, HR 1.05 (95% CI 0.86, 1.29). Modeling had little impact on the HR (1.09 {95% CI 0.89, 1.33) nor did the addition of risk factors (HR 1.00 {95% CI 0.81, 1.23). Aspirin use was not associated with incident CHD for any Framingham risk level. Findings were similar when including all aspirin users (not just those taking aspirin prophylactically), and when examining associations with all-cause mortality. There was no excess hospitalized bleeding in the aspirin users. Conclusion: Aspirin was not associated with lower risk for incident acute CHD overall, or within race, gender, or Framingham Risk Score.

Authors and Affiliations

Stephen P. Glasser, Martha Hovater, Todd M. Brown, George Howard, Monika M. Safford

Keywords

Related Articles

Evidence of Overlapping Infections of Dengue, Malaria and Typhoid in Febrile Patients Attending a Tertiary Health Facility in Uyo, South-South Nigeria

Background: Malaria, typhoid, and dengue have become significant diseases worldwide, especially in Africa due to their increasing endemicity. Similarities in signs and symptoms in infected individuals make it difficult f...

New Insight into the Mechanisms of the Anti-hyperglycemic Action of Metformin

Although metformin is currently one of the most frequently prescribed drugs for the treatment of type 2 diabetes, the precise mechanism of its molecular action is not fully understood. Metformin induces mild and transien...

Awareness of the Oral Cancer Risk Factors in People from Nothern-Eastern Region of Poland

Background: The aim of the study presented in this paper is to investigate patient knowledge about the existence of oral cancer and the awareness of the impact of smoking on the development of this malignancy. Methods: P...

Coronary Artery Disease, Hyperlipidemia, Microorganisms and Statins

Coronary artery disease is a leading cause of death in the world. İnflammation has an important role in the pathogenesis of atherosclerosis. We have known that microorganisms are responsible in atherosclerosis and since...

Small Cell Lung Carcinoma with Overt Cutaneous Metastasis; Unusual Case

Small cell lung carcinoma is a rapidly progressive neuroendocrine tumor having a poor prognosis. It is considered as a systemic disease, because it has diffuse involvement, distant organ metastasis, and regional lymphati...

Download PDF file
  • EP ID EP348843
  • DOI 10.9734/BJMMR/2014/11212
  • Views 55
  • Downloads 0

How To Cite

Stephen P. Glasser, Martha Hovater, Todd M. Brown, George Howard, Monika M. Safford (2014). Aspirin as Primary Prevention of Acute Coronary Heart Disease Events. Journal of Advances in Medicine and Medical Research, 4(34), 5357-5367. https://europub.co.uk/articles/-A-348843